Table 4.
Treatment (range) | Number (%) | Median duration of all treatments in years (range) |
---|---|---|
Albendazole* | 30/34 (88.2) | 0.55 (0.05–4.7) |
Praziquantel* | 20/34 (61.8) | 0.96 (0.01–4.3) |
Combined* | 20/34 (61.8) | NA |
Corticosteroids* | 30/34 (88.2) | 1.09 (0.02–5.0) |
Methotrexate | 17/34 (50.0) | 1.37 (0.08–7.92) |
Etanercept* | 11/34 (34.2) | 0.81 (0.11–1.91) |
Anakinra | 1/30 (0.03) | 1.61 |
NA = not applicable.
* Three persons with calcified subarachnoid did not receive treatment and one person (who received aborted inadequate treatment cysticidal and etanercept) was excluded.